Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Is This Biotech Stock a Buy for Under $3?

Biotech company Bionano Genomics (BNGO) has beaten analysts’ top-line estimate in the third quarter. However, its cash and cash equivalents balance has declined year-over-year. Therefore, is it a buy now under $3? Read on to find out….

StockNews.com

California’s ‘tripledemic’ of viruses is on the rise. Here’s how to care for a sick loved one

Trying to avert a heavy surge in respiratory illnesses, California’s leading public health officials once again stressed on Tuesday that state residents should do all they can to prevent the spread of COVID-19, the flu and respiratory syncytial virus, or RSV, as they gather for the holidays.

Tribune News Service

Scale of drugs problem contributes to existence of paramilitary groups, MPs told

"The harms of paramilitarism are much broader and will need a tailored and very different process."

Belfast Live

From analysis to the latest developments in health,
read the most diverse news in one place.

Gene therapy at $3.5m a dose approved for US adults with hemophilia B

Hemgenix frees patients from repeated treatments but initial cost makes it most expensive medicine in the world

The Guardian - US

China's Zhengzhou, Shenyang to tighten COVID rules

Eight districts in the central Chinese city of Zhengzhou will conduct mass COVID-19 testing for five consecutive days from Nov. 25, state television CCTV reported on Wednesday.

Reuters

As STDs proliferate, companies rush to market at-home test kits. But are they reliable?

Among the more remarkable legacies of the COVID-19 pandemic is how quickly federal regulators, the health care industry and consumers moved to make at-home testing a reliable tool for managing a public health crisis.

Tribune News Service

1 Stock to Buy Now That Could Make You Rich in 2023

Biopharmaceutical major Bristol-Myers Squibb Company (BMY) beat the consensus earnings and revenue estimates in the third quarter. Given its strong product pipeline, strategic acquisitions, discounted valuation, high profitability, strong financials, and attractive dividends, investors could buy the stock now. Read more….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Britain and South Africa agree health partnership on second day of state visit

Britain and South Africa on Wednesday announced a new health and science partnership to mark the second day of President Cyril Ramaphosa's state visit to London, the first such official guest hosted by Britain's King Charles.

Reuters

UK and South Africa to strengthen health and climate partnership

The two nations signed an agreement during South African President Cyril Ramaphosa’s state visit to the UK.

The Independent UK

COVID pill approval ups pandemic arsenal

The health ministry has granted emergency approval for a COVID-19 pill developed by Shionogi Co., opening the door for Japan's first domestically produced oral medicine for the virus to become available as soon as early December.

The Japan News/Yomiuri

Odisha launches Amlan to reduce anaemia

BHUBANESWAR: The Odisha government on Wednesday launched Anaemia Mukta Lakhya Abhiyan (Amlan), a multi-departmental campaign to reduce anaemia or haemoglobin deficiency in the state.

The Times of India

The growing menopause-at-work market

Little discussed and poorly understood, menopause — and the market for helping treat its accompanying symptoms — is gaining more attention when it comes to employer benefits.

Axios

Who can get an autumn Covid booster jab and how do I book?

Booster vaccinations are being offered to everyone in England over the age of 50

The Independent UK

New clinical trial will test whether infections need antibiotics

At present, medics may sometimes give out antibiotics unnecessarily because it is not clear whether an infection is caused by bacteria

Wales Online

Get all your
news in one place.

100’s of premium titles.
One news app.

ABC News

Medical device companies upselling products to surgeons in operating theatres, insider claims

A former marketing manager for medical device companies says company reps would go into operating theatres ostensibly to give surgeons technical support, but with the prime aim of selling more products.

The Independent UK

$3.5M gene therapy for hemophilia gets FDA approval

U.S. health regulators have approved the first gene therapy for hemophilia, a blood-clotting disorder with few treatment options

Tribune News Service

New booster shots cut risk of symptomatic COVID-19

WASHINGTON — The new bivalent COVID-19 booster shots are up to 56% more effective at preventing symptomatic COVID-19 infection than the two original COVID-19 vaccines in adults ages 18 and up, according to new data from the Centers for Disease Control and Prevention.

The Independent UK

US renews push for COVID boosters as data show they protect

Americans who have gotten the updated COVID-19 boosters appear better protected against symptomatic infection than those who haven't — at least for now

Get all your
news in one place.

100’s of premium titles.
One news app.

Reuters

Britain says monkeypox shot offers strong 78% protection

A single dose of the monkeypox vaccine provides 78% protection against the virus, according to data from England released on Tuesday that health officials said was the strongest evidence yet of its effectiveness.

WEKU

Experts are concerned Thanksgiving gatherings could accelerate a 'tripledemic'

As the holiday approaches, infectious disease specialists are bracing for the possibility that big family get-togethers and travel will propel the spread of RSV, flu and COVID-19.

The Independent UK

RSV: Single jab approved for virus that can cause deadly pneumonia in babies

RSV can lead to severe lung issues in very young children including bronchiolitis and pneumonia

Axios

America shrugs off its twindemic

Americans are too COVID-fatigued to care.

Birmingham Post

Leeds' Tissue Regenix Group strikes agreement with German distributor

The Garforth-based business has signed a multi-year deal with the Hamburg firm

Radio France Internationale

EU drugs agency concerned about rising recreational use of 'laughing gas'

The European Union's drugs agency says that recreational use of laughing gas is an increasing worry in Europe, stressing that frequent use of this gas increases the risk of poisonings, burns and nervous system damage.

The Canberra Times

ACT contact tracing app to be 'switched off'

Canberrans have not been required to check in since May.

1 … 94 95 96 97

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Centers for Disease Control and Prevention

BristolMyers Squibb Company

95 stories

Medical – Pharmaceuticals

69 stories

PHA

63 stories

Francis Crick Institute

26 stories

BNGO

15 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.